ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
After 3 doses of tailor-made treatment, an infant with a rare, life-threatening urea cycle disorder is thriving
The technique offers a less expensive approach to oligomer sequencing than mass spectrometry
Canada’s Intrepid Labs uses AI and robotics to customize formulas for new and old medicines
Cryo-EM experts make a movie of influenza’s replication machinery, which could lead to better antivirals
The Conference of the Parties to the Basel, Rotterdam, and Stockholm conventions banned the controversial pesticide and other toxic compounds, but exemptions and resistance remain
The firm says emission control equipment made the facility unprofitable
Students from all fields lose out on tens of millions of dollars in career-boosting funds this year
The firm says emission control equipment made the facility unprofitable
Rafael Luque is made an honorary professor at a ceremony at the Kremlin
Cryo-EM experts make a movie of influenza’s replication machinery, which could lead to better antivirals
After 3 doses of tailor-made treatment, an infant with a rare, life-threatening urea cycle disorder is thriving
Researchers couple AI and chemical know-how to create tools for cyclopropanation and silylation reactions